Compounding Pharmacy · , · 503A

SmartPharmaRX Review

SmartPharmaRX is a 503A licensed compounding pharmacy compounding sterile preparations in accordance with USP 797 (with USP 795 / 800 alignment) and cGMP-aligned protocols. Compounds GLP-1 therapies including tirzepatide and semaglutide, with each preparation tested for sterility, potency, endotoxin, and stability before release. Specific state license footprint is described as 'select states' but not enumerated on the public site.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503AState pharmacy licenseUSP 797 sterile compoundingcGMP aligned
Location: ,
States licensed: 0
6.0
★★★☆☆3/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from SmartPharmaRX — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.2

Fella Health

Men's weight loss

Starting price: $299/mo

Get started →Read review Fella Health →
7.6

SkinnyRx

Mainstream telehealth GLP-1 access

Starting price: $149.25/mo

Get started →Read review SkinnyRx →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Starting price: $79/mo

Get started →Read review Embody →
6.9

YourEra

$99 first-month entry pricing on compounded GLP-1s

Starting price: $149/mo

Get started →Read review YourEra →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

State pharmacy license
Licensed by the pharmacy's home state board of pharmacy. All US pharmacies must hold a state license at minimum.
503A
Traditional patient-specific compounding pharmacy under Section 503A — compounds individual prescriptions and is regulated primarily by its state board of pharmacy.
USP 797 sterile compounding
United States Pharmacopeia compounding standards (USP <795> non-sterile, <797> sterile, <800> hazardous drugs) — the quality chapters state boards enforce for compounded preparations.
cGMP aligned
Current Good Manufacturing Practices — the FDA standard used by pharmaceutical manufacturers, required of 503B outsourcing facilities.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

SmartPharmaRX has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for SmartPharmaRX. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-05-23 via pharmacy-directory-cross-state-audit-2026-05-23 · How we verify provider data

Frequently Asked Questions

SmartPharmaRX is a 503A compounding pharmacy based in , . It operates under state board of pharmacy licensure. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
SmartPharmaRX is headquartered in , . The pharmacy is licensed to ship to 0 US states.
SmartPharmaRX produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.